Parexel’s Oncology eBook provides new imperatives on how to adapt oncology drug development to a post-COVID world. We’ve gathered insights from Parexel experts to help companies bring new cancer therapies to patients covering four strategic imperatives: incorporating novel surrogate endpoints, leveraging new data sources, making trials patient-friendly and building value from the start. These four areas are all critical to determining which therapies will ultimately benefit patients and going forward, we believe they will shape cancer drug development.